Enovis ENOV Reconstructive — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enovis's reconstructive — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enovis's reconstructive — depreciation?
- Enovis (ENOV) reported reconstructive — depreciation of $25.73M in Q1 2026.
- How has Enovis's reconstructive — depreciation changed year-over-year?
- Enovis's reconstructive — depreciation increased by 3.5% year-over-year, from $24.87M to $25.73M.
- What is the long-term trend for Enovis's reconstructive — depreciation?
- Over 4 years (2021 to 2025), Enovis's reconstructive — depreciation has grown at a 75.5% compound annual growth rate (CAGR), from $89.09M to $845.54M.
- What does reconstructive — depreciation mean?
- This metric represents the systematic allocation of the cost of tangible long-lived assets within the Reconstructive segment over their useful lives. It reflects the wear and tear of manufacturing equipment and facilities used to produce reconstructive surgical devices. Monitoring this helps investors understand the capital intensity and asset replacement cycle of the segment.